🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 7 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/01/2020 58,00 58,00 56,60 56,93 -0,99% 2,41% 1.203.900
14/01/2020 55,87 58,21 54,67 57,50 +1,48% 6,34% 1.457.600
13/01/2020 58,00 58,00 54,19 56,66 -2,33% 6,57% 2.093.300
10/01/2020 59,04 59,80 57,65 58,01 -1,58% 3,64% 1.395.100
09/01/2020 60,46 60,65 58,58 58,94 -1,44% 3,42% 1.423.400
08/01/2020 59,72 61,29 58,75 59,80 +0,37% 4,25% 1.422.800
07/01/2020 59,13 60,40 58,22 59,58 +0,24% 3,70% 1.491.500
06/01/2020 60,91 61,13 58,73 59,44 -3,45% 3,95% 1.824.300
03/01/2020 61,94 63,21 60,77 61,56 -2,47% 3,94% 1.467.100
02/01/2020 63,62 64,00 60,75 63,12 -0,49% 5,11% 1.592.000
31/12/2019 63,94 64,98 63,21 63,43 -1,20% 2,77% 1.205.100
30/12/2019 64,50 65,20 63,20 64,20 -1,12% 3,10% 1.202.800
27/12/2019 67,15 67,24 63,71 64,93 -3,08% 5,26% 1.399.500
26/12/2019 64,55 67,98 64,34 66,99 +3,76% 5,64% 1.458.000
24/12/2019 63,61 64,70 63,02 64,56 +1,25% 2,64% 786.900
23/12/2019 64,65 65,11 63,43 63,76 +0,43% 2,60% 2.208.300
20/12/2019 67,84 68,09 63,09 63,49 -6,19% 7,37% 19.622.100
19/12/2019 66,90 68,35 65,21 67,68 +1,76% 4,69% 1.161.000
18/12/2019 65,30 67,50 64,51 66,51 +1,00% 4,58% 1.325.600
17/12/2019 65,44 67,00 63,60 65,85 +0,72% 5,20% 1.470.200
16/12/2019 64,55 65,45 61,19 65,38 -1,63% 6,60% 3.022.600
13/12/2019 66,70 68,50 65,56 66,46 -1,28% 4,41% 1.571.200
12/12/2019 68,28 69,95 65,89 67,32 -1,32% 5,95% 2.050.500
11/12/2019 70,62 71,80 67,28 68,22 -3,73% 6,40% 1.718.400
10/12/2019 68,02 72,17 68,00 70,86 +4,56% 6,13% 2.281.000
09/12/2019 67,27 69,50 66,59 67,77 +0,74% 4,32% 2.063.300
06/12/2019 66,43 69,00 65,70 67,27 +2,66% 4,97% 1.985.500
05/12/2019 66,00 66,77 62,50 65,53 -1,40% 6,47% 2.445.300
04/12/2019 62,22 66,89 61,00 66,46 -3,20% 9,46% 6.595.500
03/12/2019 62,00 72,47 60,38 68,66 +8,42% 19,50% 5.827.000